优领医药科技

U-Link Pharma is a specialized Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) headquartered in Shanghai, China. The company focuses on high-end formulation development and complex drug delivery systems, including long-acting injections, microspheres, liposomes, and nanocrystals. U-Link Pharma provides a full suite of services that encompass formulation R&D, CMC development, clinical trial material manufacturing, and global regulatory support. Their expertise is particularly geared toward the 505(b)(2) regulatory pathway, helping clients develop value-added medicines with improved efficacy or safety profiles. With state-of-the-art facilities in Shanghai and Suzhou, the company serves both domestic and international pharmaceutical firms.